Eloise Hudry Selected Research

Proteins (Proteins, Gene)

9/2023	VWA3A-derived ependyma promoter drives increased therapeutic protein secretion into the CSF.
12/2019	Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1.
9/2018	Virus vector-mediated genetic modification of brain tumor stromal cells after intravenous delivery.
1/2018	Cromolyn Reduces Levels of the Alzheimer's Disease-Associated Amyloid β-Protein by Promoting Microglial Phagocytosis.
1/2010	Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eloise Hudry Research Topics

Disease

25	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2010
10	Amyloid Plaque 01/2023 - 01/2010
3	Amyloidosis 10/2021 - 05/2014
2	Neoplasms (Cancer) 12/2019 - 09/2018
2	Asthma (Bronchial Asthma) 01/2018 - 01/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 08/2015
1	Necrosis 10/2023
1	Infections 09/2023
1	Pathologic Processes 01/2023
1	Neuroinflammatory Diseases 10/2020
1	Autistic Disorder (Autism) 12/2019
1	Astrocytoma (Pilocytic Astrocytoma) 12/2019
1	Epilepsy (Aura) 12/2019
1	Hydrocephalus (Hydrocephaly) 12/2019
1	Intellectual Disability (Idiocy) 12/2019
1	Neurologic Manifestations (Neurological Manifestations) 12/2019
1	Tuberous Sclerosis (Bourneville's Disease) 12/2019
1	Cognitive Dysfunction 01/2019
1	Nervous System Diseases (Neurological Disorders) 09/2018
1	Hyperemia 01/2018
1	Brain Diseases (Brain Disorder) 07/2017
1	Central Nervous System Diseases (CNS Diseases) 01/2017
1	Atrophy 08/2015
1	Migraine Disorders (Migraine) 08/2015
1	Huntington Disease (Huntington's Disease) 08/2015
1	Migraine with Aura (Familial Hemiplegic Migraine) 08/2015
1	Parkinson Disease (Parkinson's Disease) 08/2015
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 05/2014

Drug/Important Bio-Agent (IBA)

10	Amyloid (Amyloid Fibrils)IBA 01/2018 - 01/2010
6	Apolipoproteins E (ApoE)IBA 10/2021 - 11/2013
6	Amyloid beta-PeptidesIBA 10/2020 - 01/2010
5	Proteins (Proteins, Gene)FDA Link 09/2023 - 01/2010
5	Peptides (Polypeptides)IBA 08/2015 - 01/2010
4	CalciumIBA 01/2023 - 02/2012
4	ApolipoproteinsIBA 01/2018 - 11/2013
4	CholesterolIBA 01/2017 - 01/2010
2	Apolipoprotein E4IBA 01/2020 - 01/2018
2	CalcineurinIBA 10/2018 - 02/2012
2	Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric 01/2018 - 01/2015
2	Cholesterol 24-Hydroxylase (CYP46A1)IBA 08/2015 - 01/2010
1	Transaminases (Aminotransferases)IBA 10/2023
1	LipopolysaccharidesIBA 10/2021
1	Glycogen Synthase (Synthase I)IBA 02/2021
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Tuberous Sclerosis Complex 1 ProteinIBA 12/2019
1	Tuberous Sclerosis Complex 2 ProteinIBA 12/2019
1	trans-sodium crocetinate (crocetin)IBA 12/2019
1	tau Proteins (tau Protein)IBA 01/2019
1	Interferon-betaIBA 09/2018
1	CytokinesIBA 09/2018
1	Ibuprofen (Motrin)FDA LinkGeneric 01/2018
1	Glutamic Acid (Glutamate)FDA Link 01/2018
1	RNA (Ribonucleic Acid)IBA 07/2017
1	Protein Isoforms (Isoforms)IBA 01/2017
1	LipidsIBA 01/2017
1	Calcium Channels (Calcium Channel)IBA 08/2015
1	Nucleotide AptamersIBA 01/2014
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2012
1	Presenilin-1IBA 01/2010

Therapy/Procedure

6	Therapeutics 10/2020 - 02/2012
1	Intravenous Injections 09/2018